Latest Revenue Generation News

NoviqTech's subsidiary Coralia has inked a strategic MOU with A Healthier Earth, the climate-tech arm of Pure Data Centres Group, aiming to secure a long-term offtake of at least 70% of biochar carbon removal credits from its Great Barrier Reef project. The deal explores joint venture possibilities for a biochar production facility amid soaring demand driven by data centres and AI expansion.

Great Divide Mining has transitioned its Challenger Gold Mine in NSW from commissioning to commercial production, targeting a gold concentrate grade of 30 grams per tonne from historic tailings with minimal capital expenditure.

Green360 Technologies has produced its first commercial batch of Eco-Clay under a tolling deal with Calix, advancing its low-carbon cement alternative towards market entry in Victoria by mid-2026.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Oneview Healthcare has secured A$12.3 million from its placement and security purchase plan, though the SPP fell well short of its A$2 million target. The company will now seek shareholder approval for the final tranche of its A$19 million raise at the September AGM.

SRJ Technologies’ subsidiary ACE has secured a multi-year contract with Divetech, part of AD Ports Group, to deliver robotic inspection services across the UAE maritime network, potentially generating up to US$1.3 million over 18 months.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Red Sky Energy has locked in a binding agreement with Santos to drill the Willowie appraisal well in South Australia’s Innamincka Dome, aiming to build on recent production gains and accelerate cashflow.

Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.

IODM Limited has renewed its commercial agreement with Convera for the UK higher education sector, increasing its revenue share and shifting to a non-exclusive arrangement that broadens its market opportunities.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.